Richard Kelly – Is it possible to discontinue anticoagulation in patients with PNH?
VJHemOnc shared on X:
“Is it possible to discontinue anticoagulation in patients with PNH?
Dr Richard Kelly commented on this in a recent interview at IPIG2025, which you can watch.”
Watch the full interview on VJHemOnc to explore whether anticoagulation withdrawal is feasible—and for whom
Can anticoagulation safely be discontinued in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)? This pressing clinical question was recently addressed by Dr. Richard Kelly during an interview at the International PNH Interest Group Congress (IPIG 2025). As treatment paradigms evolve with the advent of complement inhibitors, the traditional rationale for long-term anticoagulation in PNH patients is being actively re-evaluated”.
Dr. Kelly shares insights into emerging data, individualized risk stratification, and the potential for safe de-escalation of anticoagulant therapy in select patients with controlled hemolysis and no history of thrombosis.
You can read a wide variety of new posts in Hemostasis Today.
-
May 23, 2026, 12:52Fernanda Orsi: Honor to Be Speaking on ITP Diiferential Diagnosis at the 2026 Highlights of ASH
-
May 23, 2026, 12:46Jayagowri Karthikeyan: Grateful to Receive NBEMS President’s Gold Medal for Excellence In Immunohematology and Blood Transfusion
-
May 23, 2026, 12:40Aryabhatta Sadhu: Redefining Transfusion Medicine Across Obstetrics, Gynecology, and Fetal Medicine
-
May 23, 2026, 12:03Kiana Mohammadian: Do Anti-Inflammatory Cytokines Modulate Thrombosis?
-
May 23, 2026, 11:55Zikra Tazeen Mohammad Zakriya: Exploring the Link Between Vitamin D, Stroke, and Thrombosis
-
May 23, 2026, 11:33Alessandra Bosch: Swiss Delphi Consensus Study on Thrombophilia Testing Indications
-
May 23, 2026, 11:21Dip Ghosh: How CPDA-1 Keeps Transfusions Safe and Effective
-
May 23, 2026, 08:15Alexander Krupp: Asundexian Receives Priority Review Designation from China‘s NMPA
-
May 23, 2026, 07:59Toward a Dedicated Framework for MIg-Driven Hemostatic Disorders – JTH